Severe immune-related hyperthermia followed by immune-related pneumonitis with PD-1 inhibitor (sintilimab) in small cell lung cancer: A case report

被引：12
|
作者：
Li, Yi-hui [1 ]
Zhou, Yang [1 ]
Liu, Yuan-yuan [1 ]
Zhang, Guang-ju [1 ]
Xiao, Lei [1 ]
Li, Na [1 ]
Qin, Hai-feng [2 ]
Wang, Jian-gong [1 ]
Zhang, Li [3 ]
机构：
[1] Tangshan Peoples Hosp, Dept Multimodal Therapy Oncol, 65 Shengli Rd, Tangshan 063000, Hebei, Peoples R China
[2] Nanyuan Dist 302 Hosp PLA, Dept Pulm Neoplasm Internal Med, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp, Beijing, Peoples R China
来源：
THORACIC CANCER | 2021年 / 12卷 / 11期
关键词：
small cell lung cancer; immune checkpoint inhibitors; sintilimab; hyperthermia; immune‐ related pneumonitis; ADVERSE EVENTS; PROFILES;
D O I：
10.1111/1759-7714.13967
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immune checkpoint inhibitors (ICIs) have achieved prominent efficacy in the treatment of numerous cancers, which is the most significant breakthrough in cancer therapy in recent years. However, ICIs are associated with a series of immune-related adverse events (irAEs). Pneumonitis is an uncommon but potentially fatal irAE. In the case reported here, a patient with advanced small cell lung cancer (SCLC) had rapid progression of disease following chemotherapy and received ICIs. The patient experienced severe immune-related hyperthermia followed by immune-related pneumonitis. Fortunately, a good clinical response was achieved after the patient received corticosteroids and tocilizumab.
引用
收藏
页码：1780 / 1783
页数：4
相关论文
共 50 条
  • [21] Rituximab in steroid-refractory immune-related pancreatitis: a case report
    Santoro, Armando
    Masini, Silvia
    Cavina, Raffaele
    Tronconi, Maria Chiara
    De Vincenzo, Fabio
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [22] Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitors
    Park, Hyesun
    Hatabu, Hiroto
    Ricciuti, Biagio
    Aijazi, Safiya J.
    Awad, Mark M.
    Nishino, Mizuki
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 132
  • [23] Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimens
    Zhao, Lei
    Yu, Jing
    Wang, Jing
    Li, Huihui
    Che, Juanjuan
    Cao, Bangwei
    JOURNAL OF CANCER, 2020, 11 (01): : 41 - 50
  • [24] PD-1/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events
    Mohammed, Nader
    Xiao, En-Hua
    Mohsen, Shallal
    Xiong, Zeng
    Zhou, Rongrong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] Immunogenetic variations predict immune-related adverse events for PD-1/PD-L1 inhibitors
    Xin, Zhaodan
    You, Liting
    Na, Feifei
    Li, Jin
    Chen, Min
    Song, Jiajia
    Bai, Ling
    Chen, Jie
    Zhou, Juan
    Ying, Binwu
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 124 - 136
  • [26] Management of PD-1/PD-L1 blockade immune-related skin toxicities: perspectives and issues
    Ferranti, Martina
    Cicogna, Giulia Tadiotto
    Messina, Francesco
    Alaibac, Mauro
    IMMUNOTHERAPY, 2021, 13 (10) : 795 - 798
  • [27] The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment
    Sakata, Yoshihiko
    Kawamura, Kodai
    Ichikado, Kazuya
    Shingu, Naoki
    Yasuda, Yuko
    Eguchi, Yoshitomo
    Anan, Keisuke
    Hisanaga, Junpei
    Nitawaki, Tatsuya
    Iio, Miwa
    Sekido, Yuko
    Nakan, Aiko
    Sakagami, Takuro
    LUNG CANCER, 2019, 130 : 159 - 161
  • [28] Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity
    Pellitero, Alba Moratiel
    Garcia, Maria Zapata
    Ruiz, Marta Gascon
    Arbones-Mainar, Jose Miguel
    Prado, Rodrigo Lastra del
    Isla, Dolores
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (02) : 223 - 238
  • [29] Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer
    Song, Yongchun
    Sun, Yanqin
    Sun, Tuanhe
    Tang, Ruixiang
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2020, 23 (05) : 381 - 391
  • [30] Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer
    Nakamura, Masakatsu
    Otsuka, Toshimi
    Hayashi, Ranji
    Horita, Tomoe
    Ota, Masafumi
    Sakurai, Naoko
    Takano, Hikaru
    Hayashi, Tasuku
    Kumagai, Motona
    Yamada, Sohsuke
    Arisawa, Tomiyasu
    INTERNAL MEDICINE, 2020, 59 (21) : 2711 - 2717
12345